Loading stock data…
HURA
$2.33+0.09 (+4.02%)
Market ClosedLast close May 1
TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
TuHURA Biosciences, Inc. in the Healthcare sector is trading at $2.33. The stock is currently 45% below its 52-week high of $4.20, remaining 19.5% above its 200-day moving average. Technical signals show neutral RSI of 34 and bearish MACD signal, explaining why HURA maintains its current momentum and trend strength. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 34) — potential for technical mean-reversion
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$2.33
Potential Upside
5%
Whystock Fair Value$2.45
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to overcome prim...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$170.39M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-143.57%
Volume
Today's trading volume
509,460
Recent News
Is TuHURA Biosciences (HURA) One of the Unstoppable Stocks That Could Double Your Money?
TuHURA Biosciences Inc. (NASDAQ:HURA) is one of the 10 Unstoppable Stocks That Could Double Your Money. TuHURA Biosciences Inc. (NASDAQ:HURA) is one of the unstoppable stocks that could double your money. TuHURA announced its financial results for Q4 and the full year. The company is advancing its Phase 3 trial for IFx-2.0 as an adjunctive […]
TuHURA Biosciences, Inc.'s (NASDAQ:HURA) Shift From Loss To Profit
TuHURA Biosciences, Inc. ( NASDAQ:HURA ) is possibly approaching a major achievement in its business, so we would like...
TuHURA Biosciences, Inc.'s (NASDAQ:HURA) last week's 11% decline must have disappointed retail investors who have a significant stake
NasdaqCM:HURA 1 Year Share Price vs Fair Value Explore TuHURA Biosciences's Fair Values from the Community and select...